Be The Cure’ (BTCURE), is an IMI* funded research project which aims to develop new therapies against rheumatoid arthritis. With a total budget of EUR 35 million and 37 partners from all over Europe, it is hoped that by combining academic and industrial resources, basic understanding of disease processes and therapeutic development will be enhanced.

WP1 – 4th BTCure Workshop on Animal Models

On September 18th, 2016 the forth workshop on Animal Models in Experimental Arthritis took place in Athens, Greece. The workshop was organized by Prof. George Kollias (Fleming) and was funded by the BTCure workshop support. The three day workshop involved BTCure partners from Academia and Industry in addition to external speakers, leaders in their field of expertise. For the meeting summary, please click here.

Functional Genomics workshop in London


jane and fiona  audience

10-12th February 2016, Kings College London arranged and hosted, by BTCure PI Andrew Cope,  a very interesting and successful workshop on functional genomics (the full program can be downloaded here)

The aims of the workshop were
• To highlight new advances in understanding the functional impact of genetic variation in immune mediated inflammatory and related diseases.
• To provide delegates with an experimental framework for investigating the functional basis of genetic variation.
• To provide opportunities for investigators and their collaborators to network in this field of research.


Patient research partners

In BTCure we have several patient research partners involved. This is in many ways very fruitful for both the project per se, the indiviual researchers as well as for the patient research partners. Follow the discussion between Heidi Wähämaa, researcher at Karolinska and Eva Johansson, patient research partner, in this nice story (click here for the full report).